How viable is home spirometry as a clinical endpoint in fibrotic ILD?
The COVID-19 pandemic has resulted in new challenges in lung clinical trials, such as patients being unable to access hospital spirometry.
[vital_featured_image]
A recent study reported by Khan et al. investigated the potential of using home spirometry as a clinical endpoint in fibrotic ILD. The study concluded that “Home spirometry in fibrotic ILD is feasible and non-inferior to hospital spirometry.” Read the full report by Khan et al.
Klinische Studien
Dienstleistungen für klinische Studien
Wir sichern den Erfolg Ihrer Studie mit unserer Expertise in der Atemwegsdiagnostik und innovativen Lösungen für klinische Studien.
Project
Clinical
Training
Software
eCOA
